|
|
||||||||
Clinical Chemistry, Vol 36, 1969-1973, Copyright © 1990 by American Association for Clinical Chemistry
RW Yatscoff, KR Copeland and CJ Faraci
Department of Clinical Chemistry, Health Sciences Clinical Research Centre, Winnipeg, Manitoba, Canada.
We report here the evaluation of the Abbott TDx assay with a monoclonal antibody for selectively quantifying cyclosporine (CsA) in whole blood. Over the clinically relevant concentration ranges, results with this assay demonstrated within- and between-run CVs of less than 2.5% and 5%, respectively; sensitivity of 25 micrograms/L; good analytical recovery (100.3%); and linearity with whole-blood specimens. The percentage cross-reactivity of the major CsA metabolites varied from 15.3% for AM9 (M-1), 8.2% for AM1 (M-17), and 3.7% for AM4N (M-21), to less than 3% for the other metabolites tested. Results with the TDx assay (y) correlated well with those by the Sandimmune selective RIA (x; Sandoz) with blood specimens from 44 renal-transplant recipients (n = 44, x= 187.3, y = 198.9, y = 5.49 + 1.03x, r = 0.987). The TDx values were on average 24% higher than those by HPLC (x') with the same patients' specimens (n = 44, x' = 159.9, y = 198.9, y = 15.9 + 1.14x', r = 0.967). We conclude that the Abbott TDx monoclonal antibody assay provides a rapid, precise, and accurate means for quantifying CsA in whole blood.
The following articles in journals at HighWire Press have cited this article:
![]() |
M. Rheeders, M. Bouwer, and T. C. Goosen Drug-drug interaction after single oral doses of the furanocoumarin methoxsalen and cyclosporine. J. Clin. Pharmacol., July 1, 2006; 46(7): 768 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. PODDER, S. M. STEPKOWSKI, K. L. NAPOLI, J. CLARK, R. R. VERANI, T.-C. CHOU, and B. D. KAHAN Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1059 - 1071. [Abstract] [Full Text] |
||||
![]() |
W. Steimer Performance and Specificity of Monoclonal Immunoassays for Cyclosporine Monitoring: How Specific Is Specific? Clin. Chem., March 1, 1999; 45(3): 371 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Wallemacq and K. Alexandre Evaluation of the New AxSYM Cyclosporine Assay: Comparison with TDx Monoclonal Whole Blood and Emit Cyclosporine Assays Clin. Chem., March 1, 1999; 45(3): 432 - 435. [Full Text] [PDF] |
||||
![]() |
M. G. Scott, K. G. Hock, D. L. Crimmins, and P. M. Fracasso HPLC method for monitoring SDZ PSC 833 in whole blood Clin. Chem., March 1, 1997; 43(3): 505 - 510. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |